106 related articles for article (PubMed ID: 19604123)
21. Comparative study of the efficacy and tolerability of a unique topical scar product vs white petrolatum following shave biopsies.
Kircik LH
J Drugs Dermatol; 2013 Jan; 12(1):86-90. PubMed ID: 23377333
[TBL] [Abstract][Full Text] [Related]
22. Novel therapies for scar reduction and regenerative healing of skin wounds.
Rhett JM; Ghatnekar GS; Palatinus JA; O'Quinn M; Yost MJ; Gourdie RG
Trends Biotechnol; 2008 Apr; 26(4):173-80. PubMed ID: 18295916
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children.
de Oliveira GV; Sanford AP; Murphy KD; de Oliveira HM; Wilkins JP; Wu X; Hawkins HK; Kitten G; Chinkes DL; Barrow RE; Herndon DN
Wound Repair Regen; 2004; 12(4):404-11. PubMed ID: 15260805
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation.
Profyris C; Tziotzios C; Do Vale I
J Am Acad Dermatol; 2012 Jan; 66(1):1-10; quiz 11-2. PubMed ID: 22177631
[TBL] [Abstract][Full Text] [Related]
25. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling].
Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds.
Vooijs DP; Walboomers XF; Parker JA; Von den Hoff JW; Jansen JA
J Biomed Mater Res A; 2004 Sep; 70(3):402-11. PubMed ID: 15293313
[TBL] [Abstract][Full Text] [Related]
27. The effects of brain natriuretic peptide on scar formation in incisional rat wounds.
Taira BR; Singer AJ; McClain SA; Zimmerman T
Acad Emerg Med; 2008 Oct; 15(10):945-8. PubMed ID: 18795903
[TBL] [Abstract][Full Text] [Related]
28. New potential antiscarring approaches.
Liu W; Wu X; Gao Z
Wound Repair Regen; 2011 Sep; 19 Suppl 1():s22-31. PubMed ID: 21793963
[TBL] [Abstract][Full Text] [Related]
29. The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.
Lin RY; Adzick NS
Semin Pediatr Surg; 1996 Aug; 5(3):165-74. PubMed ID: 8858763
[TBL] [Abstract][Full Text] [Related]
30. Improving scar quality: a prospective clinical study.
Atiyeh BS; Ioannovich J; Al-Amm CA; El-Musa KA; Dham R
Aesthetic Plast Surg; 2002; 26(6):470-6. PubMed ID: 12621572
[TBL] [Abstract][Full Text] [Related]
31. [The morphologic characteristics of scar tissues and the new clinicomorphologic classification of human skin scars].
Shekhter AB; Guller AE
Arkh Patol; 2008; 70(1):6-13. PubMed ID: 18368800
[TBL] [Abstract][Full Text] [Related]
32. Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
Bush J; So K; Mason T; Occleston NL; O'Kane S; Ferguson MW
Dermatol Res Pract; 2010; 2010():. PubMed ID: 20811604
[TBL] [Abstract][Full Text] [Related]
33. Topical high molecular weight hyaluronan reduces radicular pain post laminectomy in a rat model.
Massie JB; Schimizzi AL; Huang B; Kim CW; Garfin SR; Akeson WH
Spine J; 2005; 5(5):494-502. PubMed ID: 16153575
[TBL] [Abstract][Full Text] [Related]
34. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
35. Scar redness in humans: how long does it persist after incisional and excisional wounding?
Bond JS; Duncan JAL; Mason T; Sattar A; Boanas A; O'Kane S; Ferguson MWJ
Plast Reconstr Surg; 2008 Feb; 121(2):487-496. PubMed ID: 18300967
[TBL] [Abstract][Full Text] [Related]
36. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
37. Effects of human recombinant growth hormone on donor-site healing in burned adults.
Losada F; García-Luna PP; Gómez-Cía T; Garrido M; Pereira JL; Marín F; Astorga R
World J Surg; 2002 Jan; 26(1):2-8. PubMed ID: 11898025
[TBL] [Abstract][Full Text] [Related]
38. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
39. Induction of cementogenesis and periodontal ligament regeneration by recombinant human transforming growth factor-beta3 in Matrigel with rectus abdominis responding cells.
Ripamonti U; Parak R; Petit JC
J Periodontal Res; 2009 Feb; 44(1):81-7. PubMed ID: 18973524
[TBL] [Abstract][Full Text] [Related]
40. Ontogeny of expression of transforming growth factor-beta and its receptors and their possible relationship with scarless healing in human fetal skin.
Chen W; Fu X; Ge S; Sun T; Zhou G; Jiang D; Sheng Z
Wound Repair Regen; 2005; 13(1):68-75. PubMed ID: 15659038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
